evolv glp 1 GLP-1 Biomimetic Recently Approved Wegovy Pill Expands
Description
GLP-1 Loss 10% Diabetes Risk 2.6x Cardiac Risk 1.6x Sleep Apnea Risk 2.0x Your BMI is 29.2, which is higher than 38% of the population
Orforgliprons no-cold-chain logistics may push more starts through primary care and expand ex-U.S
Yi comes in
They lost 445,000 Medicare Advantage members and expect to lose up to 550,000 by the end of 2025
